Biolase, Inc.
BIOL
BIOL was delisted on the 18th of June, 2024.
18 hedge funds and large institutions have $116K invested in Biolase, Inc. in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
13% more funds holding
Funds holding: 16 → 18 (+2)
65% less capital invested
Capital invested by funds: $336K → $116K (-$219K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$64K |
| 2 |
Millennium Management
New York
|
+$56.9K |
| 3 |
HF
HRT Financial
New York
|
+$49.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$35.6K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$24.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$208K |
| 2 |
ZF
Zhang Financial
Portage,
Michigan
|
-$15.4K |
| 3 |
Two Sigma Investments
New York
|
-$12K |
| 4 |
BlackRock
New York
|
-$11.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.3K |
BIOL Hedge Fund Activity: Q1 2024 in Review
18 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q1 2024, worth a combined $116K — down 65% from $336K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BIOL positions and 7 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Virtu Financial, adding an estimated $64K. The largest seller was Anson Funds Management, exiting entirely with an estimated $208K sold.
- 18 institutional investors held Biolase, Inc. (BIOL) as of Q1 2024, up from 16 in Q4 2023.
- Funds reported $116K of Biolase, Inc. stock for Q1 2024, down 65% quarter-over-quarter.
- 9 funds opened new Biolase, Inc. positions in Q1 2024 and 7 closed out, a net change of +2 holders.
- The largest Biolase, Inc. buyer in Q1 2024 was Virtu Financial, an estimated $64K added.
- The largest Biolase, Inc. seller in Q1 2024 was Anson Funds Management, an estimated $208K sold.
Based on aggregated 13F filings for Q1 2024.